BIIB Stock Sees Decline of Approximately -4.66% in Last Five Days
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Biogen Inc shares valued at $19,817 were sold by Singhal Priya on Apr 02 ’24. At $213.09 per share, Singhal Priya sold 93 shares. The insider’s holdings dropped to 4,886 shares […]
Biogen Inc [BIIB] Records 50-Day SMA of $223.01
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Biogen Inc shares valued at $19,817 were sold by Singhal Priya on Apr 02 ’24. At $213.09 per share, Singhal Priya sold 93 shares. The insider’s holdings dropped to 4,886 shares worth approximately $0.98 million following the […]
Biogen Inc (BIIB) rating reiterates by Needham
Biogen Inc’s recent filing unveils that its Head of Development Singhal Priya unloaded Company’s shares for reported $57962.0 on Feb 22 ’24. In the deal valued at $221.23 per share,262 shares were sold. As a result of this transaction, Singhal Priya now holds 4,886 shares worth roughly $1.01 million. Then, Singhal Priya sold 108 shares, […]
Analysts review Biogen Inc’s rating
Biogen Inc’s filing revealed that its Head of Development Singhal Priya unloaded Company’s shares for reported $57962.0 on Feb 22 ’24. In the deal valued at $221.23 per share,262 shares were sold. As a result of this transaction, Singhal Priya now holds 4,886 shares worth roughly $1.04 million. Then, Singhal Priya sold 108 shares, generating […]
More To Go Or Is It Over? – Biogen Inc. (BIIB)
Biogen Inc. (NASDAQ:BIIB) does about 1.15M shares in volume on a normal day but saw 782852 shares change hands in Friday trading. The company now has a market cap of 40.18B USD. Its current market price is $278.38, marking an increase of 2.52% compared to the previous close of $271.53. The 52 week high reached […]
Biogen (BIIB), Amgen (AMGN) Fell While Alibaba (BABA), Apollo Global (APO, Capri holding (CPRI), 3M (MMM) Surged
Biogen Inc. (BIIB) fell -5.21% to $263.25. For the three months ended, the organization posted a profit, with increased competition impacting its multiple sclerosis treatment. Guidance for 2021 from the biotechnology firm is also small. Adjusted EPS finished at $4.58 for the three months and sales were $2.85 billion. The consensus, according to FactSet, was […]